EMG
DMK

ETF Managers Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

ETF Managers Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89
Closed -$6K – 809
2021
Q1 		$6K Buy
+89
New +$6.93K ﹤0.01% 662

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return

ETF Managers Group's DMK Position: Q2 2021 in Review

ETF Managers Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2021, closing a stake of 89 shares — an estimated $6K sold.

ETF Managers Group first reported a position in DMK in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2021.

  • ETF Managers Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2021 after selling out during the quarter.
  • ETF Managers Group sold 89 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2021, an estimated $6K.
  • ETF Managers Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2021 and held it in 1 quarter.
  • ETF Managers Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $6K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2021.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.